| Dr Mark A Bigalke, MD | |
|
400 Ne Mother Joseph Pl, Vancouver, WA 98664-3200 | |
| (360) 828-5396 | |
| (360) 828-5455 |
| Full Name | Dr Mark A Bigalke |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 400 Ne Mother Joseph Pl, Vancouver, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184611998 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | MD16828 (Oregon) | Secondary |
| 207L00000X | Anesthesiology | MD00029015 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark A Bigalke, MD Po Box 5157, Vancouver, WA 98668-5157 Ph: (360) 828-5396 | Dr Mark A Bigalke, MD 400 Ne Mother Joseph Pl, Vancouver, WA 98664-3200 Ph: (360) 828-5396 |
News Archive
Intra-Cellular Therapies, Inc. (ITI) announced at a recent conference on neuropsychiatric diseases the results from a recently completed Phase I clinical study demonstrating ITI-007, the Company's lead antipsychotic drug, interacts with important targets in the living human brain. These key targets are critical to drug action in many neuropsychiatric and related disorders.
University of Louisville researchers are a step closer to eliminating periodontal disease through their work to develop synthetic molecules that prevent a bacteria responsible for the disease from spreading throughout the mouth.
Some mental health and learning disability nurses are too ready to restrain patients, according to speakers at the NMC's national conference on the management of violence in health care.
MICARDIS® is the first treatment in its class to be approved for this indication. The EMEA approval is the second major milestone for MICARDIS® in cardiovascular protection. It follows the approval by the US FDA for the reduction of the risk of myocardial infarction (heart attack), stroke, or death from cardiovascular (CV) causes in patients 55 years of age or older at high risk of developing major CV events who are unable to take ACE inhibitors.
The increasing prevalence of lifestyle-related health risks coupled with the lack of resources in preventative healthcare calls for novel and cost-efficient methods for supporting citizens in their independent health and well-being management. Behaviour modification is an efficient way of preventing chronic diseases and other lifestyle-related health problems, provided that the healthy behaviours are sustained over the long term.
› Verified 4 days ago
Dr. Tyler Justin Paradis, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 400 Ne Mother Joseph Pl, Vancouver, WA 98664 Phone: 360-828-5396 Fax: 360-828-5455 | |
Dr. Ramon Larios, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 400 Ne Mother Joseph Pl, Vancouver, WA 98664 Phone: 360-828-5396 Fax: 360-828-5455 | |
Dr. Allen R Zeitlin, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 400 Ne Mother Joseph Pl, Vancouver, WA 98664 Phone: 360-828-5396 | |
Dr. Jordan Graham Graybill, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 920 Ne 112th Ave Ste 104, Vancouver, WA 98684 Phone: 360-795-1002 | |
Abbas Navroze Asgerally, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2312 Ne 129th St, Vancouver, WA 98686 Phone: 360-546-8950 Fax: 360-696-5445 | |
Dr. Andrea P Fyffe Burris, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 400 Ne Mother Joseph Pl, Vancouver, WA 98664 Phone: 360-828-5396 Fax: 360-828-5455 |